Skip to content

Advertisement

Open Peer Review Reports for: Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
4 Apr 2017 Submitted Original manuscript
9 Jun 2017 Reviewed Reviewer Report - Davide Pareyson
30 Jun 2017 Reviewed Reviewer Report - Laura Obici
2 Aug 2017 Author responded Author comments - David Adams
Resubmission - Version 2
2 Aug 2017 Submitted Manuscript version 2
21 Aug 2017 Author responded Author comments - David Adams
Resubmission - Version 3
21 Aug 2017 Submitted Manuscript version 3
Publishing
22 Aug 2017 Editorially accepted
11 Sep 2017 Article published 10.1186/s12883-017-0948-5

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement